|Bid||4.3800 x 3000|
|Ask||5.0000 x 4000|
|Day's Range||4.2706 - 4.4850|
|52 Week Range||1.9600 - 6.0200|
|Beta (5Y Monthly)||1.94|
|PE Ratio (TTM)||88.80|
|Earnings Date||Aug 11, 2021 - Aug 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.25|
Accuray (ARAY) introduces RayStation treatment planning support for CyberKnife Radiotherapy System and other radiation therapy devices.
Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the company's CyberKnife® M6™** and S7™** Robotic, Radiotherapy Systems. RayStation helps enable clinicians to create treatment plans for the CyberKnife M6 and S7 Systems and other conventional radiation therapy devices in one unified treatment planning system (TPS), making it easier to integrate the Accuray systems within the radiation oncology department. Integration will help to improv
Accuray's (ARAY) ClearRT imaging capability, which is now widely available following receipt of the CE Mark, offers better precision and accuracy in radiation therapy.